![]() | K&S Corporate Headquarters Kulicke & Soffa Pte Ltd 23A Serangoon North Ave 5 #01-01, Singapore 554369 |
+65-6880-9600 main +65-6880-9580 fax www.kns.com Co. Regn. No. 199902120H | |
Quarterly Results - U.S. GAAP | |||
Fiscal Q2 2020 | Change vs. Fiscal Q2 2019 | Change vs. Fiscal Q1 2020 | |
Net Revenue | $150.7 million | up 30.1% | up 4.4% |
Gross Profit | $69.3 million | up 24.6% | down 1.6% |
Gross Margin | 46.0% | down 190 bps | down 280 bps |
Income from Operations | $11.1 million | up 544% | down 17.2% |
Operating Margin | 7.3% | up 950 bps | down 200 bps |
Net Income | $11.9 million | up 430.6% | down 11.9% |
Net Margin | 7.9% | up 1100 bps | down 150 bps |
EPS – Diluted(a) | $0.19 | up 480% | down 9.5% |
(a) | GAAP diluted net earnings per share reflects any dilutive effect of outstanding restricted stock units and stock options, but that effect is excluded when calculating GAAP diluted net (loss) per share because it would be anti-dilutive. For the three months ended March 30, 2019, 0.8 million shares of restricted stock units and stock options were excluded due to the Company's net loss. |
Fiscal Q2 2020 | Change vs. Fiscal Q2 2019 | Change vs. Fiscal Q1 2020 | |
Income from Operations | $12.9 million | up 1175% | down 17.3% |
Operating Margin | 8.6% | up 970 bps | down 220 bps |
Net Income | $13.7 million | up 6750% | down 12.7% |
Net Margin | 9.1% | up 890 bps | down 180 bps |
EPS - Diluted | $0.22 | NA | down 8.3% |
• | Net revenue of $150.7 million. |
• | Gross margin of 46.0%. |
• | Net income of $11.9 million or $0.19 per share; non-GAAP net income of $13.7 million or $0.22 per share. |
• | Cash, cash equivalents, and short-term investments, net of bank overdraft facility were $524.7 million as of March 28, 2020. |
Kulicke & Soffa Industries, Inc. | |
Joseph Elgindy | |
Investor Relations & Strategic Initiatives | |
P: +1-215-784-7518 | |
F: +1-215-784-6180 | |
Three months ended | Six months ended | ||||||||||||||
March 28, 2020 | March 30, 2019 | March 28, 2020 | March 30, 2019 | ||||||||||||
Net revenue | $ | 150,741 | $ | 115,908 | $ | 295,038 | $ | 273,116 | |||||||
Cost of sales | 81,438 | 60,335 | 155,371 | 142,744 | |||||||||||
Gross profit | 69,303 | 55,573 | 139,667 | 130,372 | |||||||||||
Operating expenses: | |||||||||||||||
Selling, general and administrative | 27,331 | 27,235 | 53,755 | 55,768 | |||||||||||
Research and development | 29,067 | 29,577 | 57,359 | 59,380 | |||||||||||
Amortization of intangible assets | 1,820 | 1,869 | 3,637 | 3,746 | |||||||||||
Restructuring | 9 | (643 | ) | 426 | (612 | ) | |||||||||
Total operating expenses | 58,227 | 58,038 | 115,177 | 118,282 | |||||||||||
Income/(loss) from operations | 11,076 | (2,465 | ) | 24,490 | 12,090 | ||||||||||
Other income (expense): | |||||||||||||||
Interest income | 2,675 | 3,865 | 5,514 | 7,691 | |||||||||||
Interest expense | (661 | ) | (254 | ) | (1,244 | ) | (505 | ) | |||||||
Income before income taxes | 13,090 | 1,146 | 28,760 | 19,276 | |||||||||||
Income tax expense | 1,162 | 4,672 | 3,295 | 15,242 | |||||||||||
Share of results of equity-method investee, net of tax | 40 | 29 | 100 | 72 | |||||||||||
Net income /(loss) | $ | 11,888 | $ | (3,555 | ) | $ | 25,365 | $ | 3,962 | ||||||
Net income per share: | |||||||||||||||
Basic | $ | 0.19 | $ | (0.05 | ) | $ | 0.40 | $ | 0.06 | ||||||
Diluted | $ | 0.19 | $ | (0.05 | ) | $ | 0.39 | $ | 0.06 | ||||||
Cash dividends declared per share | $ | 0.12 | $ | 0.12 | $ | 0.24 | $ | 0.24 | |||||||
Weighted average shares outstanding: | |||||||||||||||
Basic | 63,679 | 65,930 | 63,675 | 66,530 | |||||||||||
Diluted | 64,219 | 65,930 | 64,266 | 67,344 | |||||||||||
Three months ended | Six months ended | ||||||||||||||
Supplemental financial data: | March 28, 2020 | March 30, 2019 | March 28, 2020 | March 30, 2019 | |||||||||||
Depreciation and amortization | $ | 4,769 | $ | 5,237 | $ | 9,528 | $ | 10,006 | |||||||
Capital expenditures | 2,775 | 2,234 | 5,099 | 7,176 | |||||||||||
Equity-based compensation expense: | |||||||||||||||
Cost of sales | 183 | 160 | 415 | 310 | |||||||||||
Selling, general and administrative | 2,695 | 2,330 | 5,430 | 5,255 | |||||||||||
Research and development | 844 | 811 | 1,486 | 1,609 | |||||||||||
Total equity-based compensation expense | $ | 3,722 | $ | 3,301 | $ | 7,331 | $ | 7,174 | |||||||
As of | |||||||
March 28, 2020 | March 30, 2019 | ||||||
Backlog of orders 1 | $ | 136,353 | $ | 89,439 | |||
Number of employees | 2,929 | 2,747 | |||||
1. | Represents customer purchase commitments. While the Company believes these orders are firm, they are generally cancellable by customers without penalty. |
As of | |||||||
March 28, 2020 | September 28, 2019 | ||||||
ASSETS | |||||||
CURRENT ASSETS | |||||||
Cash and cash equivalents | $ | 392,307 | $ | 364,184 | |||
Short-term investments | 248,000 | 229,000 | |||||
Accounts and other receivable, net of allowance for doubtful accounts of $501 and $597, respectively | 199,793 | 195,830 | |||||
Inventories, net | 106,178 | 89,308 | |||||
Prepaid expenses and other current assets | 24,149 | 15,429 | |||||
TOTAL CURRENT ASSETS | 970,427 | 893,751 | |||||
Property, plant and equipment, net | 55,647 | 72,370 | |||||
Operating right-of-use assets | 22,692 | — | |||||
Goodwill | 55,946 | 55,691 | |||||
Intangible assets, net | 39,757 | 42,651 | |||||
Deferred tax assets | 6,975 | 6,409 | |||||
Equity investments | 7,427 | 6,250 | |||||
Other assets | 2,027 | 2,494 | |||||
TOTAL ASSETS | $ | 1,160,898 | $ | 1,079,616 | |||
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||
CURRENT LIABILITIES | |||||||
Short term debt | $ | 115,617 | $ | 60,904 | |||
Accounts payable | 50,530 | 36,711 | |||||
Operating lease liabilities | 5,236 | — | |||||
Accrued expenses and other current liabilities | 78,296 | 64,533 | |||||
Income taxes payable | 12,358 | 12,494 | |||||
TOTAL CURRENT LIABILITIES | 262,037 | 174,642 | |||||
Financing obligation | — | 14,207 | |||||
Deferred income taxes | 33,690 | 32,054 | |||||
Income taxes payable | 74,469 | 80,290 | |||||
Operating lease liabilities | 18,550 | — | |||||
Other liabilities | 9,754 | 9,360 | |||||
TOTAL LIABILITIES | 398,500 | 310,553 | |||||
SHAREHOLDERS' EQUITY | |||||||
Common stock, no par value | 532,912 | 533,590 | |||||
Treasury stock, at cost | (365,095 | ) | (349,212 | ) | |||
Retained earnings | 604,013 | 594,625 | |||||
Accumulated other comprehensive loss | (9,432 | ) | (9,940 | ) | |||
TOTAL SHAREHOLDERS' EQUITY | $ | 762,398 | $ | 769,063 | |||
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $ | 1,160,898 | $ | 1,079,616 | |||
Three months ended | Six months ended | ||||||||||||||
March 28, 2020 | March 30, 2019 | March 28, 2020 | March 30, 2019 | ||||||||||||
Net cash provided by operating activities | $ | 14,055 | $ | 27,334 | $ | 39,083 | $ | 83,335 | |||||||
Net cash (used in)/provided by investing activities | (131,466 | ) | 138,962 | (24,979 | ) | 73,689 | |||||||||
Net cash provided by/(used in) financing activities | 12,106 | (25,176 | ) | 14,258 | (59,092 | ) | |||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 238 | 275 | (239 | ) | 257 | ||||||||||
Changes in cash, cash equivalents and restricted cash | (105,067 | ) | 141,395 | 28,123 | 98,189 | ||||||||||
Cash and cash equivalents, beginning of period | 497,374 | 277,942 | 364,184 | 321,148 | |||||||||||
Cash and cash equivalents, end of period | $ | 392,307 | $ | 419,337 | $ | 392,307 | $ | 419,337 | |||||||
Short-term investments | 248,000 | 208,000 | 248,000 | 208,000 | |||||||||||
Total cash, cash equivalents and short-term investments | $ | 640,307 | $ | 627,337 | $ | 640,307 | $ | 627,337 | |||||||
Three months ended | ||||||||||||
March 28, 2020 | March 30, 2019 | December 28, 2019 | ||||||||||
Net revenue | $ | 150,741 | $ | 115,908 | $ | 144,297 | ||||||
U.S. GAAP income/(loss) from operations | 11,076 | (2,465 | ) | 13,414 | ||||||||
U.S. GAAP operating margin | 7.3 | % | (2.1 | )% | 9.3 | % | ||||||
Pre-tax non-GAAP items: | ||||||||||||
Amortization related to intangible assets acquired through business combination- selling, general and administrative | 1,820 | 1,869 | 1,817 | |||||||||
Restructuring | 9 | (643 | ) | 417 | ||||||||
Non-GAAP income/(loss) from operations | $ | 12,905 | $ | (1,239 | ) | $ | 15,648 | |||||
Non-GAAP operating margin | 8.6 | % | (1.1 | )% | 10.8 | % | ||||||
Three months ended | ||||||||||||
March 28, 2020 | March 30, 2019 | December 28, 2019 | ||||||||||
Net revenue | $ | 150,741 | $ | 115,908 | $ | 144,297 | ||||||
U.S. GAAP net income/(loss) | 11,888 | (3,555 | ) | 13,477 | ||||||||
U.S. GAAP net margin | 7.9 | % | (3.1 | )% | 9.3 | % | ||||||
Non-GAAP adjustments: | ||||||||||||
Amortization related to intangible assets acquired through business combination- selling, general and administrative | 1,820 | 1,869 | 1,817 | |||||||||
Restructuring | 9 | (643 | ) | 417 | ||||||||
Income tax expense- Tax Reform | — | 2,499 | — | |||||||||
Net income tax benefit on non-GAAP items | (27 | ) | 28 | (51 | ) | |||||||
Total non-GAAP adjustments | $ | 1,802 | $ | 3,753 | $ | 2,183 | ||||||
Non-GAAP net income | $ | 13,690 | $ | 198 | $ | 15,660 | ||||||
Non-GAAP net margin | 9.1 | % | 0.2 | % | 10.9 | % | ||||||
U.S. GAAP net income per share: | ||||||||||||
Basic | 0.19 | (0.05 | ) | 0.21 | ||||||||
Diluted(a) | 0.19 | (0.05 | ) | 0.21 | ||||||||
Non-GAAP adjustments per share:(b) | ||||||||||||
Basic | 0.03 | 0.05 | 0.03 | |||||||||
Diluted | 0.03 | 0.05 | 0.03 | |||||||||
Non-GAAP net income per share: | ||||||||||||
Basic | $ | 0.22 | $ | — | $ | 0.24 | ||||||
Diluted(c) | $ | 0.22 | $ | — | $ | 0.24 | ||||||
(a) | GAAP diluted net earnings per share reflects any dilutive effect of outstanding restricted stock units and stock options, but that effect is excluded when calculating GAAP diluted net (loss) per share because it would be anti-dilutive. For the three months ended March 30, 2019, 0.8 million shares of restricted stock units and stock options were excluded due to the Company's net loss. |
(b) | Non-GAAP adjustments per share includes amortization related to intangible assets acquired through business combinations, costs associated with restructuring, income tax expense related to the Tax Cuts and Jobs Act of 2017 as well as tax benefits or expense associated with the foregoing non-GAAP items. |
(c) | Non-GAAP diluted net earnings per share reflects any dilutive effect of outstanding restricted stock units and stock options. |